Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Nathan M. Hinkle"'
Autor:
Andrew M. Fleming, Alisa L. Phillips, Justin A. Drake, Megan G. Gross, Danny Yakoub, Justin Monroe, Nathan M. Hinkle, David Shibata, Elizabeth H. Wood
Publikováno v:
Journal of Gastrointestinal Surgery. 27:573-584
Parastomal hernia is a debilitating complication of stoma creation. Parastomal hernia repair with mesh reduces recurrence rates in open and laparoscopic settings. Recent comparative studies conflict with previously pooled data on optimal mesh repair
Autor:
Jeremiah L. Deneve, Justin J. Monroe, Evan S. Glazer, David Shibata, Leah E. Hendrick, Paxton V. Dickson, Denise L. Wong, Nathan M. Hinkle, Whitney M. Guerrero
Publikováno v:
The American Journal of Surgery. 222:395-401
BACKGROUND Practice guidelines recommend neoadjuvant chemoradiation (NCR) for locally advanced rectal cancer (LARC). We examined guideline adherence in a healthcare system serving a region with socioeconomic disparities and poor cancer outcomes. METH
Autor:
Denise L. Wong, Alexis Holland, Mehmet Kocak, Mace Coday, Caroline Brown, Justin J. Monroe, Nathan M. Hinkle, Jeremiah L. Deneve, Evan S. Glazer, David Shibata
Publikováno v:
The American surgeon.
Objective Enhanced Recovery ERP protocols (ERP) have improved surgical outcomes in patients undergoing elective colon cancer (CC) surgery; however, efficacy in different populations may vary. We examined the impact of an ERP in a population with high
Autor:
Leah E. Hendrick, Renee L. Levesque, Jeremiah L. Deneve, Nathan M. Hinkle, David Shibata, Danny Yakoub, Paxton V. Dickson, Evan S. Glazer, Justin J. Monroe
Publikováno v:
World Journal of Surgery. 44:973-979
In the USA, most patients with clinical stage II/III rectal cancer receive neoadjuvant chemoradiation (chemo/XRT) over 5–6 weeks followed by a 6–10-week break before proctectomy. As chemotherapy is delivered at radio-sensitizing doses, there is e
Autor:
Deepti M. Reddi, Tengda Lin, Yosef Nasseri, Laura A. Lambert, Biljana Gigic, Robert W. Decker, Eiman Firoozmand, Mukta K. Krane, Cornelia M. Ulrich, Bartley Pickron, William M. Grady, Erin M. Siegel, Alessandro Fichera, Sheetal Hardikar, Nathan M. Hinkle, Mary P. Bronner, Zuri Murrell, David M. J. Hoffman, Beth A. Moore, Jennifer Ose, Adetunji T. Toriola, Mika Sinanan, Matthew G. Mutch, Anita R. Peoples, Cory T. Bernadt, Eric A. Swanson, Ravi Moonka, Jessica N. Cohan, Johanna Nattenmueller, Jolanta Jedrzkiewicz, Jane C. Figueiredo, Ulrike Wallin, Andrew Eugene Hendifar, Christopher I. Li, Lyen C. Huang, Magnus von Knebel-Doeberitz, Julian Sanchez, Justin J. Monroe, Maryliza S. El-Masry, Stephanie L. Schmit, Kyle G. Cologne, Alexandra Gangi, Domenico Coppola, Peter Schirmacher, David Shibata, Deyali Chatterjee, Karen Zaghiyan, Seth Felder, Courtney L. Scaife, Sophie Dessureault, Paul D. Lampe, Matthias Kloor, Esther Herpel, Hans-Ulrich Kauczor, Stacey A. Cohen, Caroline Himbert, Jun Gong, Alexis Ulrich
Publikováno v:
Cancers, vol 13, iss 15
Cancers
Cancers, Vol 13, Iss 3817, p 3817 (2021)
Volume 13
Issue 15
Cancers
Cancers, Vol 13, Iss 3817, p 3817 (2021)
Volume 13
Issue 15
Early-onset colorectal cancer has been on the rise in Western populations. Here, we compare patient characteristics between those with early- (<
50 years) vs. late-onset (≥50 years) disease in a large multinational cohort of colorectal cance
50 years) vs. late-onset (≥50 years) disease in a large multinational cohort of colorectal cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c9ac27e6d83efe0aee89d013f0352e
https://escholarship.org/uc/item/5zx2f8rm
https://escholarship.org/uc/item/5zx2f8rm
Autor:
Justin J. Monroe, Paxton V. Dickson, Nathan M. Hinkle, David Shibata, Jacob D Buckner, Evan S. Glazer, Jeremiah L. Deneve, Whitney M. Guerrero, Leah E. Hendrick
Publikováno v:
The American surgeon. 87(2)
Background In the United States, patients with clinical stage II or III rectal cancer typically receive neoadjuvant chemoradiation therapy (chemo/XRT) over a 5-6 week period followed by a 6-10 week break prior to proctectomy. In the current study, we
Autor:
Nathan M. Hinkle, Paxton V. Dickson, Andrew M Davidoff, Zachary E. Stiles, Jeremiah L. Deneve, Gitonga Munene
Publikováno v:
The American Surgeon. 84:776-782
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has improved outcomes for selected patients with peritoneal carcinomatosis and often requires ostomy creation. We examined the impact of ostomy creation in a newly estab
Autor:
Nathan M. Hinkle, Evan S. Glazer, David Shibata, Justin J. Monroe, Andrew M. Fleming, Veronica Lippuner, Leah E. Hendrick, Andrew Dyer, Jeremiah L. Deneve
Publikováno v:
Journal of the American College of Surgeons. 233:e185
Autor:
Vandana Botta, Gitonga Munene, Paxton V. Dickson, John P. Sharpe, Jeremiah L. Deneve, Nathan M. Hinkle
Publikováno v:
The American Surgeon. 83:633-639
Improved oncological outcomes after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in highly selected patients have been well documented. The extensive nature of the procedure adversely affects quality of life (QoL
Autor:
David Shibata, Whitney M. Guerrero, Evan S. Glazer, Nathan M. Hinkle, Denise Wong, Leah E. Hendrick, Jeremiah L. Deneve, Justin J. Monroe
Publikováno v:
Journal of Clinical Oncology. 38:71-71
71 Background: Quality and practice guidelines from the American College of Surgeons Commission on Cancer (CoC) and the National Comprehensive Cancer Network (NCCN) recommend neoadjuvant chemoradiation (NCR) for locally advanced rectal cancer (LARC).